Consumers survey results of for 1 quarter of 2024 in category Dermatology, means for external use / The drug for the treatment of psoriasis and dermatitis
The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year. |
|
I quarter (january—march) |
|
II quarter (april—june) |
|
III quarter (july—september) |
|
IV quarter (october—december) |
|
1. |
Тримістин-Дарниця (Darnitsa)
|
75.00% |
5 |
|
2. |
Карбодерм (Darnitsa)
|
25.00% |
1.67 |
|
2. |
Преднікарб-Дарниця (Darnitsa)
|
25.00% |
1.67 |
|
–. |
Aqualan L (Orion Pharma) |
0.00% |
0 |
|
–. |
Депантол крем (Stada)
|
0.00% |
0 |
|
–. |
Псоріатен (DHU) |
0.00% |
0 |
|
–. |
Скін-кап (Cheminova) |
0.00% |
0 |
|
–. |
Стерокорт (Фітофарм) |
0.00% |
0 |
|
–. |
Файнер (Progress pharma) |
0.00% |
0 |
| |